Dr. Ryan, who specializes in noninvasive diagnostics, was named one of America’s Best Doctors in 2009.
Dr. Ryan earned his medical degree at The Ohio State University College of Medicine and completed his residency at the University of Virginia Hospital in Charlottesville, Va. He also completed a research fellowship in nuclear cardiology at the University of Virginia Hospital and a clinical cardiology fellowship at Ohio State’s College of Medicine.
Dr. Ryan has extensively published abstracts, book chapters and peer-reviewed journal articles. He also has made numerous invited presentations on nuclear and cardiac MRI techniques.
He successfully raised nearly $12 million in support of both cardiovascular research and Ohio State’s Richard M. Ross Heart Hospital. Dr. Ryan’s clinical interests include nuclear cardiology, echocardiography, heart disease in athletes and cardiac magnetic resonance imaging.
- Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2014, 2015
Ohio State University College of Medicine
Specialties and conditions I treat
- Cardiovascular Disease
- Cardiovascular Diseases
- Nuclear Medicine
- Coronary Care Units
- Angina Pectoris
- Angina, Stable
- Angina, Unstable
- Aortic Valve Insufficiency
- Aortic Valve Stenosis
- Heart Murmurs
- Systolic Murmurs
Locations where I practice
Richard M. Ross Heart Hospital
More about my work
American Board of Internal Medicine
American Board of Internal Medicine (Subspecialty: Cardiovascular)
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 07/27/2016, Dr. Ryan has reported no financial relationships with medical device, research and/or drug companies.